ADAR1 Capital Management, LLC
Reporting owner on Forms 3, 4 and 5, CIK 1940272.
- Also a 13F filer: ADAR1 Capital Management, LLC
- In the filer group ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC reported on 1 issuer in 15 filings, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| INM · InMed Pharmaceuticals Inc.CIK 1728328 | 10% owner | 2 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| INM · InMed Pharmaceuticals Inc.Common Shares | 2026-10-08 | P bought | +2,256 | $1.3283 | 945,924 | Form 4 |
| INM · InMed Pharmaceuticals Inc.Common Shares | 2026-10-07 | P bought | +3,046 | $1.33 | 943,668 | Form 4 |
| INM · InMed Pharmaceuticals Inc.Common Shares | 2026-10-06 | P bought | +5,601 | $1.3277 | 940,622 | Form 4 |
| InMed Pharmaceuticals Inc. Common Shares | 2026-10-05 | P bought | +18,182 | $1.33 | 935,021 | Form 4 |
| InMed Pharmaceuticals Inc. Common Shares | 2026-10-02 | P bought | +8,307 | $1.33 | 916,839 | Form 4 |
| InMed Pharmaceuticals Inc. Common Shares | 2026-10-01 | P bought | +16,431 | $1.3298 | 908,532 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001940272-26-000023 | InMed Pharmaceuticals Inc. | 2026-10-08 | ||
| 13G/A 0001104659-26-114415 | INM | 2026-10-07 | ||
| Form 4 0001940272-26-000022 | InMed Pharmaceuticals Inc. | 2026-10-05 | ||
| 13F-HR 0001940272-26-000015 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-26-000005 | Quarter ended 2026-03-31 | 2026-05-18 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001940272-26-000003 | Quarter ended 2025-12-31 | 2026-02-18 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-26-000002 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-25-000008 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-25-000005 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-25-000003 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-25-000001 | Quarter ended 2024-12-31 | 2025-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001940267-24-000005 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001940267-24-000001 | Quarter ended 2024-06-30 | 2024-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-24-000003 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001940272-24-000002 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set |